PoNS Therapy for Stroke Survivors
Trial Summary
What is the purpose of this trial?
Primary Objective: To further evaluate the aspects of safety related to PoNS therapy in chronic stroke survivors. Secondary Objectives: To further evaluate the efficacy of PoNS on improving dynamic gait and balance, establishing durability of effect, risk of falling and fall rate. As well as adherence to PoNS device utilization. Exploratory Objectives: To further evaluate quality of life to measure physical, mental, behavioral, and general health, as well as functional decline (\> 30% on gait or balance improvement at endpoint) during the 12-week follow-up.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does exclude participants using certain stimulation devices or those who have had neurostimulation therapy recently.
What data supports the effectiveness of the treatment PoNS Therapy for stroke survivors?
Research on neuromodulation techniques, like transcranial direct current stimulation (tDCS), shows promising results in helping stroke patients recover motor function. These techniques, which include PoNS Therapy, aim to stimulate the brain to improve movement and reduce disability after a stroke.12345
Is PoNS Therapy safe for humans?
The safety of PoNS Therapy, also known as Portable Neuromodulation Stimulator, has been evaluated in various studies, including those on vagus nerve stimulation (VNS) for stroke recovery. VNS, which is similar in its approach to neuromodulation, has been used safely in thousands of patients for conditions like seizures, suggesting a general safety profile for similar neuromodulation therapies.678910
How is PoNS Therapy different from other treatments for stroke recovery?
PoNS Therapy is unique because it uses a non-invasive device to stimulate the tongue, which is believed to help improve brain function and motor recovery in stroke survivors. This approach differs from traditional stroke treatments that often focus on physical rehabilitation or medications, as it directly targets the nervous system to enhance recovery.1231112
Eligibility Criteria
This trial is for chronic stroke survivors who are experiencing issues with walking and balance. Participants should be able to commit to the study duration and follow-up requirements. Specific eligibility details aren't provided, but typically, trials exclude individuals with conditions that could interfere with the treatment or skew results.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment Part 1
Participants undergo DGB training in clinic supervised by the Trainer
Treatment Part 2
Participants continue DGB training at home, unsupervised, with weekly follow-ups
Follow-up
Participants are monitored for safety and effectiveness after treatment, encouraged to continue physical rehabilitation
Treatment Details
Interventions
- PoNS Therapy
PoNS Therapy is already approved in Canada for the following indications:
- Gait deficit due to mild and moderate symptoms from stroke
- Chronic balance deficit due to mild-to-moderate traumatic brain injury
Find a Clinic Near You
Who Is Running the Clinical Trial?
Helius Medical Inc
Lead Sponsor
Antonella Favit-VanPelt
Lead Sponsor